Correlation Between Evergy, and Biodexa Pharmaceticals

Can any of the company-specific risk be diversified away by investing in both Evergy, and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evergy, and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evergy, and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Evergy, and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evergy, with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evergy, and Biodexa Pharmaceticals.

Diversification Opportunities for Evergy, and Biodexa Pharmaceticals

-0.36

Correlation Coefficient

Evergy,  Biodexa Pharmaceticals

Very good diversification

The 3 months correlation between Evergy, and Biodexa is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Evergy, and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Evergy, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evergy, are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Evergy, i.e., Evergy, and Biodexa Pharmaceticals go up and down completely randomly.

Pair Corralation between Evergy, and Biodexa Pharmaceticals

Given the investment horizon of 90 days Evergy, is expected to generate 2.17 times less return on investment than Biodexa Pharmaceticals. But when comparing it to its historical volatility, Evergy, is 14.5 times less risky than Biodexa Pharmaceticals. It trades about 0.09 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  596.00  in Biodexa Pharmaceticals on October 7, 2024 and sell it today you would lose (146.00) from holding Biodexa Pharmaceticals or give up 24.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Evergy,  vs.  Biodexa Pharmaceticals

Evergy,

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Evergy, are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Evergy, is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Biodexa Pharmaceticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biodexa Pharmaceticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Biodexa Pharmaceticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Evergy, and Biodexa Pharmaceticals

The main advantage of trading using opposite Evergy, and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evergy, position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.

The idea behind Evergy, and Biodexa Pharmaceticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.